Healthcare
Wales Life Sciences Fund leads €12m series-B for Apitope
Cash will fund drug development and move to Wales
Sofinnova backs Asceneuron’s CHF 30m series-A
Company is a spin-off from Merck Serono
Karolinska Development exits XSpray Microparticles
New owner will invest SEK 18m to support clinical trials
Atlas et al. in $30m round for Replimune
Series-A backers include Atlas Venture, Forbion and Omega Funds
Parquest et al. buy Creadev’s Homeperf
Creadev had acquired business from minority owner 3i in 2009
Rainbow Seed Fund appoints Romanos as consultant venture partner
New recruit leaves position as CEO of Rainbow Seed Fund-backed Crescendo
Hannover Finanz acquires Frey&Winkler
GP hopes for good returns from medical engineerer
Bridgepoint acquires Balt
Second French foray for GP’s €4bn fifth buyout fund
Magnum acquires Orliman from Riverside
Divestment comes nine months after company bolted on Soft Medical
EQT eyes PLN 200m HTL-Strefa listing
GP targets late October for Warsaw listing
SHS and BWK buy minority stake in NDD Medizintechnik
Company operates in Europe, the US and Asia
Deal in Focus: Forbion to reap 50x on $1.55bn Dezima sale
Sale of Dezima could result in a staggering 50x return for Forbion
Archimed acquires RehabWorks
UK health provider to acquire Right Corecare from Manpower
Archimed takes minority stake in Primo
GP invests on all-equity basis from first fund
Finance Wales-backed Creo Medical raises $8.45m
Welsh medical equipment maker has raised $20.7m to date
Forbion’s Dezima sold to Amgen
VC exits two years after backing the company's creation
Omnes et al. in funding round for SeniorAdom
Business eyeing international expansion in 2016
Catapult exits Lumora
Catapult first invested in the company in 2011
Quadrivio and Vertis in €1m-plus round for Glomeria
Dialysis firm to undertake clinical trials and bring production in-house
VC-backed Acacia to list in October
Offering size understood to lie around the £150m mark
Go Capital et al. in €2.2m seed round for Mitricares
Second round to feature a French implant designer in a week
New Science Ventures et al. in €28m series-A for Novadip
Largest Benelux early-stage round recorded by unquote” so far in 2015
Gimv et al. in €31.3m series-C for Biom’up
Round comes three years after €6.8m series-B
Cinven exits AmCo in £2.3bn trade sale
GP built group via merger of Mercury Pharma and Amdipharm